GENEVA, Oct. 5 -- HALYARD THERAPEUTICS filed a patent application (US2026/020555) for “CHIMERIC ANTIGEN RECEPTOR-EXPRESSING PHAGOCYTIC CELLS AND METHODS OF MAKING AND USING THE SAME”. With publication no. WO/2026/206955, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 40/31
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....